Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

528P - Comparison of endoscopic ultrasound-guided tissue acquisition for solid liver masses: Menghini needle with a lateral reverse bevel vs. Franseen needle

Date

27 Jun 2024

Session

Poster Display session

Presenters

Jae Hee CHO

Citation

Annals of Oncology (2024) 35 (suppl_1): S205-S215. 10.1016/annonc/annonc1483

Authors

J.H. CHO1, S. Lee1, C. Jung1, S. Jang1, E. Kim2

Author affiliations

  • 1 Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul/KR
  • 2 Gachon University Gil Medical Center, Incheon/KR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 528P

Background

Endoscopic ultrasound-guided liver biopsy (EUS-LB) has recently garnered increasing attention. While reports suggest fine-needle biopsy (FNB) needles have a higher yield compared to fine-needle aspiration (FNA) needles, controversy remains regarding the superior diagnostic performance among different types of FNB needles. This study aims to evaluate the performance and safety of two commonly used FNB needles for diagnosing pancreatic lesions, specifically when applied to liver lesions.

Methods

We retrospectively analyzed patients who underwent EUS-LB for solid liver lesions between November 2014 and September 2023. The study evaluated two different needles: a Menghini needle, which has a core trap with a lateral reverse bevel, and a Franseen needle.

Results

Among 66 patients evaluated, the technical success rate was 100%. The combined diagnostic rate from cell block and histology was 89.4%, with an overall adverse event rate of 3.0%. Tissue retrieval rates were 67.5% for the Reverse-bevel needle and 96.2% for the Franseen needle (p=0.006). Adverse event rates were 2.5% and 3.8%, respectively (p=0.674). The FNAB accuracy of the Reverse-bevel needle group was 89.7%, with a sensitivity of 89.5% and specificity of 100.0%. In contrast, the Franseen needle group exhibited an FNAB accuracy of 92.6%, a sensitivity of 92.3%, and specificity of 100.0%. Table: 528P

Diagnostic yield between Reverse-bevel needle group and Franseen needle group

Reverse-bevel needle (n=40) Franseen needle (n=26) p-value
Biopsy specimen retrieval success, n (%) 27 (67.5) 25 (96.2) 0.006
Technical success, n (%) 40 (100.0) 26 (100.0)
Adverse events, n (%) 0.674
Immediate bleeding 1 (2.5) 1 (3.8)
Delated bleeding 0 (0.0) 0 (0.0)
Pancreatitis 0 (0.0) 0 (0.0)
Other 0 (0.0) 0 (0.0)
FNAB diagnostic yield, % (cell block + histology)
Accuracy 89.74 (76.42 - 95.94) 92.59 (76.63 - 97.94) 0.692
Sensitivity 89.47 (75.87 - 95.83) 92.31 (75.86 - 97.86) 0.698
Specificity 100.00 (20.65 - 100.00) 100.00 (20.65 - 100.00) N/A
PPV 100.00 (89.85 - 100.00) 100.00 (86.20 - 100.00) N/A
NPV 20.00 (3.62 - 62.45) 33.33 (6.15 - 79.23) 0.221

FNAB: Fine-needle aspiration biopsy; NPV: Negative predictive value; PPV: Positive predictive value

Conclusions

The Franseen needle demonstrated better tissue specimen retrieval than the Reverse-bevel needle for solid liver lesions. No other significant performance differences were observed between the two needles. This suggests that while both needles are effective, the choice may depend on specific biopsy requirements.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.